Close
4

Promoted Content Promoted Content

X

Company profile for Recipharm AB

Client EmailClient Virtual Booth
RECIPHARM AB
  • Connect with Us...

  • Corporate Presentation

  • Device Contract Manufacturing

  • Stability Studies

  • Exploring New Propellants For pMDIs

  • Extractables & Leachables For Inhalation Products

  • Strategies For First In Human (FIH) Studies

  • Impurity Identification

  • Inhalation And Nasal Product Development

  • Inhalation And Nasal Product Manufacturing

  • Recipharm Inhalation Solutions

  • Recipharm Pathway To Clinic ®

  • SPRAYVIEW®

  • Successful Drug Development in the Early Clinical Phase

  • Recipharm Analytical Solutions

  • Microstructural Sameness in Semi Solid Formulations

  • Inhalation Aerosol & Nasal Spray Development Sprayview

  • Challenges of Developing Inhalation Products Using Multiple APIs

  • APIs Product List 2020

  • All Services

  • Packaging

  • Analytical

  • API Manufacturing

  • Drug Product Manufacturing

  • API & Drug Product Development

PharmaCompass

Virtual Booth Brightest Minds in the CDMO industry - From early Development to Commercial Manufacturing

Recipharm was established in Sweden in 1995 and has since grown to become a leading Contract Development and Manufacturing Organisation (CDMO).Headquartered in Jordbro, we employ around 2,200 people and the Recipharm B-share (RECI B) is listed on NASDAQ Stockholm.For over 20 years we have focussed on supporting pharmaceutical companies in taking their products from early development through to commercial manufacturing. Throughout the entire product lifecycle, we are there for our clients. Time and time again, we have delivered innovative solutions.
Recipharm-RM
Recipharm AB
Sweden Flag
Country
Country
SWEDEN
Address
Address
Box 603 SE-101 32 Stockholm
Telephone
Telephone
+ 46 8 602 52 00
Contact Info
Others

left grey arrow
right gray arrow
  • Corporate Presentation
  • Device Contract Manufacturing
  • Stability Studies
  • Exploring New Propellants For pMDIs
  • Extractables & Leachables For Inhalation Products
  • Strategies For First In Human (FIH) Studies
  • Impurity Identification
  • Inhalation And Nasal Product Development
  • Inhalation And Nasal Product Manufacturing
  • Recipharm Inhalation Solutions
  • Recipharm Pathway To Clinic ®
  • SPRAYVIEW®
  • Successful Drug Development in the Early Clinical Phase
  • Recipharm Analytical Solutions
  • Microstructural Sameness in Semi Solid Formulations
  • Inhalation Aerosol & Nasal Spray Development Sprayview
  • Challenges of Developing Inhalation Products Using Multiple APIs
  • APIs Product List 2020

https://www.pharmacompass.com/pdf/party/content/recipharm-ab-party-content-1593008072.pdf

https://www.pharmacompass.com/pdf/party/content/recipharm-ab-party-content-1612853332.pdf

https://www.pharmacompass.com/pdf/party/content/recipharm-ab-party-content-1612853268.pdf

https://www.pharmacompass.com/pdf/party/content/recipharm-ab-party-content-1612853188.pdf

https://www.pharmacompass.com/pdf/party/content/recipharm-ab-party-content-1612853018.pdf

https://www.pharmacompass.com/pdf/party/content/recipharm-ab-party-content-1612852868.pdf

https://www.pharmacompass.com/pdf/party/content/recipharm-ab-party-content-1612852732.pdf

https://www.pharmacompass.com/pdf/party/content/recipharm-ab-party-content-1612851466.pdf

https://www.pharmacompass.com/pdf/party/content/recipharm-ab-party-content-1612851384.pdf

https://www.pharmacompass.com/pdf/party/content/recipharm-ab-party-content-1612851274.pdf

https://www.pharmacompass.com/pdf/party/content/recipharm-ab-party-content-1612850569.pdf

https://www.pharmacompass.com/pdf/party/content/recipharm-ab-party-content-1612850376.pdf

https://www.pharmacompass.com/pdf/party/content/recipharm-ab-party-content-1612849234.pdf

https://www.pharmacompass.com/pdf/party/content/recipharm-ab-party-content-1585143364.pdf